ChanTest hires Chris Mathes as CCO

CLEVELAND, OH, USA – Clinical research firm ChanTest announced the hiring of Chris Mathes, Ph.D., M.B.A. as its new chief commercial officer (CCO) starting September 1^st. As its new CCO, Dr Mathes will oversee all sales, marketing, and customer relations activities at ChanTest. He will also contribute to the forward looking and strategic guidance of ChanTest as a global player in the clinical research organization (CRO) industry.

"Chris is a real ion channel guy," said Dr Arthur "Buzz" Brown, CEO, president and founder of ChanTest. "As CCO, he brings a unique mix of science and business to our company in order to make ChanTest's interface to the world even better."

Dr Mathes earned his Ph.D. in Neuroscience from the University of California Los Angeles and his M.B.A. from Rutgers University. His papers on ion channels have been published in several peer reviewed journals over the past two decades. In the last ten years, Dr. Mathes has been a pioneer in the development and implementation of automated patch clamp systems for ion channel safety testing and drug discovery.

"I'm really excited about this opportunity at ChanTest. ChanTest is already the market leading ion channel CRO. My goal is to further enhance the brand and to expand the business. I want to make sure that every pharmaceutical or biotech lab in the world accesses the ion channel and scientific expertise available at ChanTest,” Dr. Mathes said.